Provided by Tiger Trade Technology Pte. Ltd.

Insulet

148.29
-0.3700-0.25%
Volume:456.39K
Turnover:67.71M
Market Cap:10.27B
PE:28.00
High:151.16
Open:149.99
Low:146.81
Close:148.66
52wk High:354.88
52wk Low:126.40
Shares:69.26M
Float Shares:69.07M
Volume Ratio:0.26
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.30
EPS(LYR):3.48
ROE:26.02%
ROA:9.71%
PB:7.22
PE(LYR):42.62

Loading ...

Analysts’ Top Healthcare Picks: Alnylam Pharma (ALNY), Insulet (PODD)

TIPRANKS
·
May 27

Insulet Is Maintained at Buy by BTIG

Dow Jones
·
May 27

Goldman Sachs Adjusts Price Target on Insulet to $205 From $237, Maintains Buy Rating

MT Newswires Live
·
May 27

U.S. RESEARCH ROUNDUP- Agilent Technologies, Fedex, Synopsys

Reuters
·
May 27

Insulet Narrows Legal Path As Delaware Forum Rule Meets Share Pressure

Simply Wall St.
·
May 27

Insulet price target lowered to $235 from $260 at BTIG

TIPRANKS
·
May 27

Stocks to Watch: Zscaler, Verra Mobility, Digital Turbine, Insulet

Dow Jones
·
May 27

Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost

Reuters
·
May 27

Insulet Flags Manufacturing Issue Affecting 7M Insulin Pods

Dow Jones
·
May 27

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipods

MT Newswires Live
·
May 27

Insulet initiates voluntary medical device correction for certain Omnipod lots

TIPRANKS
·
May 27

Insulet Corp - Does Not Expect Impact to Long-Term Growth Profile or 2026 Guidance - SEC Filing

THOMSON REUTERS
·
May 27

Insulet Corp - Expects up to $50 Mln of Costs in 2026 Due to Device Correction, Excluded From Adj Results - SEC Filing

THOMSON REUTERS
·
May 27

Insulet Corp - Does Not Anticipate Disruption to Shipments, Product Availability, or New Customer Starts - SEC Filing

THOMSON REUTERS
·
May 27

Insulet starts correction for 7 million Omnipod insulin pump pods over under-delivery risk

Reuters
·
May 27

Insulet Corp - Some Pods May Have Cannula Tear Causing Insulin Under-Delivery

THOMSON REUTERS
·
May 27

Insulet Corp - About 7 Mln Pods Included in Correction, 8.5% of 2025 Global Production

THOMSON REUTERS
·
May 27

Insulet Corp - 24 Serious Adverse Events Reported Globally; No Deaths Reported

THOMSON REUTERS
·
May 27

Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets

THOMSON REUTERS
·
May 27

SM, Casey’s, Gilead, Dominion, Insulet Trending With Analysts

TIPRANKS
·
May 23